Evidence map›Paper›PMID 26350455›Full record

ArticleThe Journal of biological chemistry2015

G0/G1 Switch Gene 2 Regulates Cardiac Lipolysis.

Christoph Heier, Franz P W Radner, Tarek Moustafa, Renate Schreiber, Susanne Grond, Thomas O Eichmann, Martina Schweiger, Albrecht Schmidt, Ines K Cerk, Monika Oberer and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Bioactive factors in endometriosis peritoneal fluid remodel human cardiomyocytes.American journal of physiology. Heart and circulatory physiology · 2026
    Article
  2. Review
  3. Recent advances on the role of G0S2.Discover oncology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Of mice and men: The physiological role of adipose triglyceride lipase (ATGL).Biochimica et biophysica acta. Molecular and cell biology of lipids · 2019
    Review
  20. Adipose Triglyceride Lipase Regulation: An Overview.Current protein & peptide science · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Christoph HeierFrom the Institute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.
Franz P W RadnerFrom the Institute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.
Tarek MoustafaFrom the Institute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria, the Laboratory of Experimental and Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine and.
Renate SchreiberFrom the Institute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.
Susanne GrondFrom the Institute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.
Thomas O EichmannFrom the Institute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.
Martina SchweigerFrom the Institute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.
Albrecht SchmidtDivision of Cardiology, Department of Internal Medicine, Medical University of Graz, A-8036 Graz, Austria, and.
Ines K CerkFrom the Institute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.
Monika ObererFrom the Institute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.
H-Christian Theusslthe Transgenic Service, Research Institute of Molecular Pathology (IMP), 1030 Vienna, Austria, and the IMBA Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria.
Jacek Wojciechowskithe Transgenic Service, Research Institute of Molecular Pathology (IMP), 1030 Vienna, Austria, and the IMBA Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria.
Josef M Penningerthe Transgenic Service, Research Institute of Molecular Pathology (IMP), 1030 Vienna, Austria, and the IMBA Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria.
Robert ZimmermannFrom the Institute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.
Rudolf ZechnerFrom the Institute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria, rudolf.zechner@uni-graz.at.
University of Graz · ATAustrian Academy of Sciences · ATMedical University of Graz · ATResearch Institute of Molecular Pathology · AT

Funding

Austrian Science Fund FWF P 25944European Research Council 340896
6 · The paper itself

Abstract

The anabolism and catabolism of myocardial triacylglycerol (TAG) stores are important processes for normal cardiac function. TAG synthesis detoxifies and stockpiles fatty acids to prevent lipotoxicity, whereas TAG hydrolysis (lipolysis) remobilizes fatty acids from endogenous storage pools as energy substrates, signaling molecules, or precursors for complex lipids. This study focused on the role of G0/G1 switch 2 (G0S2) protein, which was previously shown to inhibit the principal TAG hydrolase adipose triglyceride lipase (ATGL), in the regulation of cardiac lipolysis. Using wild-type and mutant mice, we show the following: (i) G0S2 is expressed in the heart and regulated by the nutritional status with highest expression levels after re-feeding. (ii) Cardiac-specific overexpression of G0S2 inhibits cardiac lipolysis by direct protein-protein interaction with ATGL. This leads to severe cardiac steatosis. The steatotic hearts caused by G0S2 overexpression are less prone to fibrotic remodeling or cardiac dysfunction than hearts with a lipolytic defect due to ATGL deficiency. (iii) Conversely to the phenotype of transgenic mice, G0S2 deficiency results in a de-repression of cardiac lipolysis and decreased cardiac TAG content. We conclude that G0S2 acts as a potent ATGL inhibitor in the heart modulating cardiac substrate utilization by regulating cardiac lipolysis.

Indexed as

AnimalsCell Cycle ProteinsCell LineG1 PhaseHeart Function TestsLipolysisMiceMice, Inbred C57BLMice, TransgenicMyocardiumResting Phase, Cell CycleTriglyceridesCell Cycle ProteinsG0S2 protein, mouseTriglyceridesadipose triglyceride lipase (ATGL)cardiac lipid metabolismcardiac metabolismG0S2lipid metabolismlipolysistriacylglycerol

Identifiers

PMID26350455
PMCPMC4646265
OpenAlexW1800414896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.